Anadrol Steroid – Medicines Accidental PED : A Comprehensive Guide
Introduction The Anadrol steroid, also known as oxymetholone, is a powerful anabolic steroid that is often used by body builders and athletes to improve their performance. It was originally developed in the 1950s to treat anemia and muscle wasting, but it was soon discovered that it had the potential to also increase muscle mass and...
The post Anadrol Steroid – Medicines Accidental PED : A Comprehensive Guide appeared first on Anabolicco. (Source: eHealth News EU)
Source: eHealth News EU - October 13, 2023 Category: Information Technology Authors: Team Anabolicco Tags: Articles Source Type: news
Anemia, Iron Deficit Common in Rheumatic Disease Pregnancy Anemia, Iron Deficit Common in Rheumatic Disease Pregnancy
Low maternal levels of hemoglobin and serum ferritin in pregnancy were associated with adverse infant outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 9, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news
China ’s Economy Picks Up Steam for Holiday
An employee worked on a production line at a factory in Dezhou, China, earlier this year. SINGAPORE—China’s economy is showing signs of perking up after months of anemic growth, offering a glimmer of hope for the global economy as higher interest rates squeeze consumers and businesses in the U.S.…#dezhou #singapore (Source: Reuters: Health)
Source: Reuters: Health - September 30, 2023 Category: Consumer Health News Source Type: news
Histopathology of Cold Agglutinin Disease Histopathology of Cold Agglutinin Disease
Review the characteristics of cold agglutinin disease, a type of autoimmune hemolytic anemia characterized in recent years as a distinct B-cell lymphoproliferative disease.American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2023 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
Direct Dispensing of Prenatal Supplements With Iron Reduces Anemia
WEDNESDAY, Sept. 27, 2023 -- Directly providing prenatal iron supplements significantly improves average hematocrit levels throughout pregnancy and reduces anemia in underserved patients, according to a study published online Sept. 1 in JAMA Network... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2023 Category: Pharmaceuticals Source Type: news
OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
CARY, N.C., Sept. 20, 2023 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by GSK as a specialty pharmacy provider for OJJAARATM (momelotinib). (Source: McKesson News)
Source: McKesson News - September 20, 2023 Category: Information Technology Source Type: news
Google DeepMind AI tool assesses DNA mutations for harm potential
AlphaMissense ’s predictions could help speed up research and diagnosis of rare disordersScientists at Google DeepMind have built an artificial intelligence program that can predict whether millions of genetic mutations are either harmless or likely to cause disease, in an effort to speed up research and the diagnosis of rare disorders.The program makes predictions about so-called missense mutations, where a single letter is misspelt in the DNA code. Such mutations are often harmless but they can disrupt how proteins work and cause diseases from cystic fibrosis and sickle-cell anaemia to cancer and problems with brain de...
Source: Guardian Unlimited Science - September 19, 2023 Category: Science Authors: Ian Sample Science editor Tags: Genetics Medical research Artificial intelligence (AI) Google Science Technology Computing Biology Source Type: news
FDA Approves JAK Inhibitor That Addresses Anemia in Myelofibrosis
(MedPage Today) -- The FDA approved momelotinib (Ojjaara) as the first therapy specifically for intermediate- and high-risk myelofibrosis with anemia, GSK announced.
Almost all patients with myelofibrosis develop anemia at some point during the... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 18, 2023 Category: American Health Source Type: news
FDA Approves Momelotinib for Myelofibrosis With Anemia FDA Approves Momelotinib for Myelofibrosis With Anemia
"Momelotinib is an important emerging agent for these more anemic patients," one expert said.FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 16, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
Approval is for use in myelofibrosis patients with anemia regardless of prior myelofibrosis therapy
Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease, and over 30% will discontinue treatment due to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 15, 2023 Category: Drugs & Pharmacology Source Type: news
Too Many Mothers Are Dying in Childbirth. Here ’s How They Can Be Saved
With recent reports of difficult pregnancies and births from celebrities like Beyonce, Serena Williams, and Alyson Felix, and the death of Olympian Tori Bowie during childbirth, the long-overlooked dangers of maternal and child mortality have become increasingly prominent.
In a new report published by the Bill & Melinda Gates Foundation, the global health philanthropic group highlights lagging progress in achieving United Nations (UN) goals for lowering mother and child deaths, along with innovative ways of addressing the problems with relatively inexpensive and easy to implement solutions that the group projects co...
Source: TIME: Health - September 12, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
U.S. Cannabis Recap: Reviewing The Space Ahead Of A Fresh Five-Session Set
For the better part of August, the U.S. cannabis journey remained the same: anemic volume ($15-$20M notional per session) and sentiment, for those who still cared or were still interested at all in U.S cannabis, was on life support. The week before last, not one but two U.S cannabis-focused funds…#msosmsos #bn1211hhs #dea #vangst #hhs #garlandmemo #jonathansandelman #ayrwellness #iii #scheduleiii (Source: Reuters: Health)
Source: Reuters: Health - September 10, 2023 Category: Consumer Health News Source Type: news
Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
FRIDAY, Sept. 8, 2023 -- Hypertension and anemia contribute to racial disparities in severe maternal morbidity (SMM), according to two studies published online Sept. 7 in Obstetrics& Gynecology.
Stephanie A. Leonard, Ph.D., from Stanford... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 8, 2023 Category: Pharmaceuticals Source Type: news
FDA accepts application for Roche ’s crovalimab for the treatment of PNH, a rare life-threatening blood condition
Acceptance based on the phase III COMMODORE 2 study, which demonstrated crovalimab achieved disease control and was well-tolerated in people with paroxysmal nocturnal haemoglobinuria (PNH)1If approved, crovalimab will be the first monthly subcutaneous treatment for PNH, with the option to self-administer outside of a supervised healthcare settingFiling applications have also been accepted in the EU, China and Japan, andsubmissions to other regulatory authorities around the world are ongoingBasel, 6 September 2023 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accep...
Source: Roche Investor Update - September 6, 2023 Category: Pharmaceuticals Source Type: news
What Are the Complications of Sickle Cell Trait?
Discussion
Sickle cell disease (SCD) is a group of inherited blood disorders where there are abnormal hemoglobin molecules and the red blood cells take on a characteristic sickled shape instead of a rounded shape. Sickled hemoglobin provides an evolutionary advantage of giving the individual increased protection against severe and cerebral malaria. The sickled shape doesn’t move through the vascular system as well and therefore is more likely to aggregate in small vessels causing an increased risk of vaso-occlusive disease, acute chest syndrome, splenic sequestration, and priapism. There is also an increased risk of ...
Source: PediatricEducation.org - September 4, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
